Partnering with innovators has always been the foundation of our heritage. In 1872 engineer Rudolph Jung collaborated with a pathologist to create the industrialized microtome. They took their invention to the global stage and enabled clinicians and researchers worldwide to work with precision and reproducibility. This was the first step in our journey to becoming a market leader in anatomic pathology. Today, our brand includes Aperio, Kreatech, and Novocastra to create value for our customers from sample to outcome and bring excellence to the lab.
We are part of the Danaher family, a Fortune 200 company consisting of life science leaders such as Beckman Coulter Life Sciences, Integrated DNA Technologies (IDT), Leica Microsystems, Pall and SCIEX. This provides our customers with access to a large network of life science experts and technology.
From driving innovation to advancements in science, we have long been at the forefront of technological breakthroughs. Clinical outcomes are ultimately driven by what happens in the research space. Our expansion into the life sciences opens opportunities to accelerate that journey.
We are a team of passionate pathologists, researchers and engineers, dedicated to developing products of the highest quality that bring confidence and value to our customers.
We have established Centers of Excellence across the globe and mentored interns, scientists and entrepreneurs from the top 25 leading research institutions. Scientific journal citations are a testimony to our legacy of innovative products. Researchers using our products have often been cited in top tier international journals. We believe in the value of education, and provide thought leadership through our Knowledge Pathway portal. Our expertise gives customers the confidence to use our solutions to advance their research.
We show our commitment to the future with a dedicated innovation team that drives external and internal collaboration, with the aim to deliver breakthrough technologies and instrumentation. Today, with more than 1500 patents, we are a market leader in anatomic pathology.
We collaborate with leading strategic partners including Advanced Cell Diagnostics, Nanostring, Akoya, Ultivue, Rarecyte to provide researchers with flexibility to customize their work: from DNA to RNA to protein, CTCs and imaging. We offer a wide variety of assay options, and research tools which we continue to expand.
We are eager to collaborate with the research community to develop new solutions so they can have confidence in the future of our Life Science portfolio.
Working with us, customers encounter teams dedicated to finding fresh ways to transforming scientific explorations into outcomes. It’s all part of how we help you accelerate your journey and imagine the possibilities.